Shang Hai Zheng Quan Bao·2025-11-20 18:32Core Insights - The article highlights the innovative practices of domestic pharmaceutical companies in China, particularly focusing on the advancements made by Realtime Biotech and Tailong Pharmaceutical in the context of the rapidly evolving industry [1][2]. Company Developments - Realtime Biotech, founded by Lin Changqing in 2005, has evolved from an in vitro diagnostic (IVD) company to a biopharmaceutical enterprise, marking a significant transition in its business model [1]. - Tailong Pharmaceutical emphasizes the modernization of traditional Chinese medicine through innovative practices, showcasing the integration of ancient techniques with modern technology in its production processes [1]. Industry Trends - The exploration by Realtime Biotech and Tailong Pharmaceutical reflects the broader trend of innovation within China's biopharmaceutical industry, indicating a shift towards more advanced and diversified medical solutions [2].